Indeed, alteration in the glycolytic pathway activation, such as hexokinase 2 (HK2), pyruvate kinase M2 (PKM2) and phosphofructokinase 1 (PFK1) induce glycolysis and provide pro-survival cues to tumor cells [3]. This evidence concerns the gene HK2 and neoplasm.